Tetsuo Wada
Gakushuin University
11 Papers
19 Citations
Tetsuo Wada is an academic researcher from Gakushuin University. The author has contributed to research in topics: Patent Cooperation Treaty & Patent office. The author has an hindex of 4, co-authored 11 publications.
Chat about Author
Papers
Market position, resource profile, and governance: linking Porter and Williamson in the context of international courier and small package services in Japan
TL;DR: In this article, the authors proposed a three-stage, reduced-form, endogenous self-selection model to predict a fit among three strategic choices: market position, resource profile, and organizational structure.
Alliance Structure and the Scope of Knowledge Transfer: Evidence from U.S.-Japan Agreements
Joanne E. Oxley,Tetsuo Wada +1 more
TL;DR: It is suggested that administrative structures that reduce technology leakage are a key feature of the equity joint venture, a result that is inconsistent with a “pure” knowledge-based perspective on alliances.
192
Obstacles to prior art searching by the trilateral patent offices: empirical evidence from International Search Reports
TL;DR: Evidence that geographical distance negatively affects the probability of capture of prior patents in an ISR is found and ways to design work sharing by patent offices are suggested, such that the duplication of search costs arises only when patent office search horizons overlap.
•Posted Content
Cognitive Distances in Prior Art Search by the Triadic Patent Offices: Empirical evidence from international search reports
TL;DR: Evidence shows that geographical distances negatively affect the probability of prior patents being caught in ISRs, while a lag of prior art positively affects the probability, and duplication of search costs exists only where search horizons of patent offices overlap each other.
3
Contact Hitters or Power Hitters? R&D of Family Firms in the Japanese Pharmaceutical Industry
Shigeru Asaba,Tetsuo Wada +1 more
- 01 Jan 2016
TL;DR: In this article, an analysis of Japanese pharmaceutical firms' investment in research-intensive environments is presented, finding that lower R&D investment of family firms raises the question of how such firms can survive in research intensive environments.
3